173 related articles for article (PubMed ID: 35203756)
1. Assessment of In-Vitro Synergy of Fosfomycin with Meropenem, Amikacin and Tigecycline in Whole Genome Sequenced Extended and Pan Drug Resistant
Al-Quraini M; Rizvi M; Al-Jabri Z; Sami H; Al-Muzahmi M; Al-Muharrmi Z; Taneja N; Al-Busaidi I; Soman R
Antibiotics (Basel); 2022 Jan; 11(2):. PubMed ID: 35203756
[TBL] [Abstract][Full Text] [Related]
2. Exploring Synergistic Combinations in Extended and Pan-Drug Resistant (XDR and PDR) Whole Genome Sequenced
Quraini MA; Jabri ZA; Sami H; Mahindroo J; Taneja N; Muharrmi ZA; Busaidi IA; Rizvi M
Microorganisms; 2023 May; 11(6):. PubMed ID: 37374911
[TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo Effect of Antimicrobial Agent Combinations Against Carbapenem-Resistant
Liu E; Jia P; Li X; Zhou M; Kudinha T; Wu C; Xu Y; Yang Q
Infect Drug Resist; 2021; 14():917-928. PubMed ID: 33707959
[TBL] [Abstract][Full Text] [Related]
4. In vitro evaluation of double carbapenem and colistin combinations against OXA-48, NDM carbapenemase-producing colistin-resistant Klebsiella pneumoniae strains.
Erdem F; Abulaila A; Aktas Z; Oncul O
Antimicrob Resist Infect Control; 2020 May; 9(1):70. PubMed ID: 32430058
[TBL] [Abstract][Full Text] [Related]
5. In vitro synergistic activity of fosfomycin in combination with meropenem, amikacin and colistin against OXA-48 and/or NDM-producing
Erturk Sengel B; Altinkanat Gelmez G; Soyletir G; Korten V
J Chemother; 2020 Sep; 32(5):237-243. PubMed ID: 32228228
[No Abstract] [Full Text] [Related]
6. Evaluation of double- and triple-antibiotic combinations for VIM- and NDM-producing Klebsiella pneumoniae by in vitro time-kill experiments.
Tängdén T; Hickman RA; Forsberg P; Lagerbäck P; Giske CG; Cars O
Antimicrob Agents Chemother; 2014; 58(3):1757-62. PubMed ID: 24395223
[TBL] [Abstract][Full Text] [Related]
7. Synergistic activity of fosfomycin-meropenem and fosfomycin-colistin against carbapenem resistant
Bakthavatchalam YD; Shankar A; Muthuirulandi Sethuvel DP; Asokan K; Kanthan K; Veeraraghavan B
Future Sci OA; 2020 Feb; 6(4):FSO461. PubMed ID: 32257374
[TBL] [Abstract][Full Text] [Related]
8. Fosfomycin-meropenem synergistic combination against NDM carbapenemase-producing Klebsiella pneumoniae strains.
Della Rocca MT; Di Caprio G; Colucci F; Merola F; Panetta V; Cordua E; Greco R
New Microbiol; 2023 Sep; 46(3):264-270. PubMed ID: 37747471
[TBL] [Abstract][Full Text] [Related]
9. In vitro activity of the next-generation aminoglycoside plazomicin alone and in combination with colistin, meropenem, fosfomycin or tigecycline against carbapenemase-producing Enterobacteriaceae strains.
Rodríguez-Avial I; Pena I; Picazo JJ; Rodríguez-Avial C; Culebras E
Int J Antimicrob Agents; 2015 Dec; 46(6):616-21. PubMed ID: 26391381
[TBL] [Abstract][Full Text] [Related]
10. Tigecycline in combination with other antibiotics against clinical isolates of carbapenem-resistant Klebsiella pneumoniae in vitro.
Zhang J; Yu L; Fu Y; Zhao Y; Wang Y; Zhao J; Guo Y; Li C; Zhang X
Ann Palliat Med; 2019 Nov; 8(5):622-631. PubMed ID: 31735038
[TBL] [Abstract][Full Text] [Related]
11. Propranolol restores susceptibility of XDR Gram-negative pathogens to meropenem and Meropenem combination has been evaluated with either tigecycline or amikacin.
Mabrouk SS; Abdellatif GR; Zaid ASA; Aboshanab KM
BMC Microbiol; 2023 Jul; 23(1):195. PubMed ID: 37481513
[TBL] [Abstract][Full Text] [Related]
12. In vitro activity of fosfomycin in combination with imipenem, meropenem, colistin and tigecycline against OXA 48-positive Klebsiella pneumoniae strains.
Evren E; Azap OK; Çolakoğlu Ş; Arslan H
Diagn Microbiol Infect Dis; 2013 Jul; 76(3):335-8. PubMed ID: 23726147
[TBL] [Abstract][Full Text] [Related]
13. Comparison of synergism between colistin, fosfomycin and tigecycline against extended-spectrum β-lactamase-producing Klebsiella pneumoniae isolates or with carbapenem resistance.
Ku YH; Chen CC; Lee MF; Chuang YC; Tang HJ; Yu WL
J Microbiol Immunol Infect; 2017 Dec; 50(6):931-939. PubMed ID: 28716360
[TBL] [Abstract][Full Text] [Related]
14. Synergy of fosfomycin with carbapenems, colistin, netilmicin, and tigecycline against multidrug-resistant Klebsiella pneumoniae, Escherichia coli, and Pseudomonas aeruginosa clinical isolates.
Samonis G; Maraki S; Karageorgopoulos DE; Vouloumanou EK; Falagas ME
Eur J Clin Microbiol Infect Dis; 2012 May; 31(5):695-701. PubMed ID: 21805292
[TBL] [Abstract][Full Text] [Related]
15. Dose-Dependent Synergistic Interactions of Colistin with Rifampin, Meropenem, and Tigecycline against Carbapenem-Resistant Klebsiella pneumoniae Biofilms.
Geladari A; Simitsopoulou M; Antachopoulos C; Roilides E
Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30642942
[TBL] [Abstract][Full Text] [Related]
16. Activity of Ceftazidime-Avibactam Alone and in Combination with Ertapenem, Fosfomycin, and Tigecycline Against Carbapenemase-Producing
Ojdana D; Gutowska A; Sacha P; Majewski P; Wieczorek P; Tryniszewska E
Microb Drug Resist; 2019 Nov; 25(9):1357-1364. PubMed ID: 31295055
[TBL] [Abstract][Full Text] [Related]
17. Investigation of the
Kilic U; Koroglu M; Olmez M; Altindis M
Microb Drug Resist; 2020 May; ():. PubMed ID: 32401692
[TBL] [Abstract][Full Text] [Related]
18. Pharmacodynamic Analysis of Meropenem and Fosfomycin Combination Against Carbapenem-Resistant
Mohd Sazlly Lim S; Heffernan AJ; Roberts JA; Sime FB
Microb Drug Resist; 2021 Apr; 27(4):546-552. PubMed ID: 32898467
[No Abstract] [Full Text] [Related]
19. In vitro Antimicrobial Synergy Testing of Extensively Drug-Resistant Clinical Isolates at an Organ Transplant Center in Nepal.
Karki R; Lamichhane S; Basnet BB; Dahal A; Awal BK; Mishra SK
Infect Drug Resist; 2021; 14():1669-1677. PubMed ID: 33958879
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of in vitro methods for testing tigecycline combinations against carbapenemase-producing Klebsiella pneumoniae isolates.
Papoutsaki V; Galani I; Papadimitriou E; Karantani I; Karaiskos I; Giamarellou H
J Glob Antimicrob Resist; 2020 Mar; 20():98-104. PubMed ID: 31398495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
